BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24832033)

  • 1. Neurophysiology in Huntington's disease: an update.
    Mayer IM; Orth M
    Neurodegener Dis Manag; 2014; 4(2):155-64. PubMed ID: 24832033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial magnetic stimulation as a tool for understanding neurophysiology in Huntington's disease: a review.
    Philpott AL; Fitzgerald PB; Cummins TD; Georgiou-Karistianis N
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1420-33. PubMed ID: 23727400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological measures as potential biomarkers in Huntington's disease: review and future directions.
    Nguyen L; Bradshaw JL; Stout JC; Croft RJ; Georgiou-Karistianis N
    Brain Res Rev; 2010 Sep; 64(1):177-94. PubMed ID: 20381528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory and visual evoked potentials in Huntington's disease.
    Josiassen RC; Shagass C; Mancall EL; Roemer RA
    Electroencephalogr Clin Neurophysiol; 1984 Feb; 57(2):113-8. PubMed ID: 6198151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern visual evoked potentials in Huntington's disease.
    Rizzo PA; Pierelli F; Pozzessere G; Morocutti C
    Acta Neurol (Napoli); 1980 Apr; 2(2):128-31. PubMed ID: 6446843
    [No Abstract]   [Full Text] [Related]  

  • 6. Electrophysiological deterioration over time in patients with Huntington's disease.
    Lefaucheur JP; Ménard-Lefaucheur I; Maison P; Baudic S; Cesaro P; Peschanski M; Bachoud-Lévi AC
    Mov Disord; 2006 Sep; 21(9):1350-4. PubMed ID: 16721731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical myoclonus in childhood and juvenile onset Huntington's disease.
    Rossi Sebastiano D; Soliveri P; Panzica F; Moroni I; Gellera C; Gilioli I; Nardocci N; Ciano C; Albanese A; Franceschetti S; Canafoglia L
    Parkinsonism Relat Disord; 2012 Jul; 18(6):794-7. PubMed ID: 22494662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult onset myoclonic Huntington's disease.
    Carella F; Scaioli V; Ciano C; Binelli S; Oliva D; Girotti F
    Mov Disord; 1993 Apr; 8(2):201-5. PubMed ID: 8474490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in voluntary movement execution in Huntington's disease are related to the dominant motor system: evidence from event-related potentials.
    Beste C; Konrad C; Saft C; Ukas T; Andrich J; Pfleiderer B; Hausmann M; Falkenstein M
    Exp Neurol; 2009 Mar; 216(1):148-57. PubMed ID: 19111540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatosensory evoked potentials in Huntington's disease--studies with paired stimulation.
    Kanda F; Jinnai K; Takahashi K; Abe H; Yasuda M; Tada K; Fujita T
    Electromyogr Clin Neurophysiol; 1989; 29(5):287-91. PubMed ID: 2527738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proprioceptive sensory function in Parkinson's disease and Huntington's disease: evidence from proprioception-related EEG potentials.
    Seiss E; Praamstra P; Hesse CW; Rickards H
    Exp Brain Res; 2003 Feb; 148(3):308-19. PubMed ID: 12541142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between evoked potential and neuropsychological findings in persons "at risk" for Huntington's disease.
    Josiassen RC; Curry LM; Mancall EL; Shagass C; Roemer RA
    J Clin Exp Neuropsychol; 1986 Jan; 8(1):21-36. PubMed ID: 2935556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor cortical excitability studied with repetitive transcranial magnetic stimulation in patients with Huntington's disease.
    Lorenzano C; Dinapoli L; Gilio F; Suppa A; Bagnato S; Currà A; Inghilleri M; Berardelli A
    Clin Neurophysiol; 2006 Aug; 117(8):1677-81. PubMed ID: 16793338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of subclinical brain electrical activity changes in Huntington's disease using artificial neural networks.
    de Tommaso M; De Carlo F; Difruscolo O; Massafra R; Sciruicchio V; Bellotti R
    Clin Neurophysiol; 2003 Jul; 114(7):1237-45. PubMed ID: 12842720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evoked potentials in Huntington's disease. A comparative and longitudinal study.
    Ehle AL; Stewart RM; Lellelid NA; Leventhal NA
    Arch Neurol; 1984 Apr; 41(4):379-82. PubMed ID: 6231012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of the contingent negative variation in Huntington's disease: correlations with clinical features.
    de Tommaso M; Difruscolo O; Sciruicchio V; Specchio N; Livrea P
    J Neurol Sci; 2007 Mar; 254(1-2):84-9. PubMed ID: 17300807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurophysiological abnormalities in the Westphal variant of Huntington's disease.
    Töpper R; Schwarz M; Lange HW; Hefter H; Noth J
    Mov Disord; 1998 Nov; 13(6):920-8. PubMed ID: 9827616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal neuroimaging biomarkers in Huntington's Disease.
    Rees EM; Scahill RI; Hobbs NZ
    J Huntingtons Dis; 2013; 2(1):21-39. PubMed ID: 25063427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal functional magnetic resonance imaging of cognition in preclinical Huntington's disease.
    Wolf RC; Sambataro F; Vasic N; Wolf ND; Thomann PA; Landwehrmeyer GB; Orth M
    Exp Neurol; 2011 Oct; 231(2):214-22. PubMed ID: 21726553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal characterization of the visual network in Huntington's disease gene carriers.
    Gregory S; Odish OFF; Mayer I; Mills J; Johnson EB; Scahill RI; Rothwell J; Rees G; Long JD; Tabrizi SJ; Roos RAC; Orth M
    Clin Neurophysiol; 2019 Nov; 130(11):2053-2059. PubMed ID: 31541982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.